Jeffrey Kindler - 2010 CEO Pay

Jeffrey Kindler - Pfizer

Jeffrey Kindler, Pfizer CEO

Total Compensation: $24.7 million

Details: Pfizer execs did particularly well this year, with both Jeffrey Kindler and Ian Read receiving significant raises. Kindler's 2010 compensation rose to $24.7 million, nearly $10 million higher than 2009's $14.9 million payday. Despite suddenly leaving the company in early December, Kindler received $4.9 million in "other compensation," as well as $3.2 million in non-executive incentive pay and $9 million in stock options, in part due to the Wyeth purchase under his tenure.

Kindler's successor, Ian Read, received a nearly $8 million raise, thanks to his new title, with his 2010 total pay topping off at $17.4 million (we elected to hold off including Read until next year, but we're sure he'll make the 2011 list).

The Pfizer executive salaries--as well as that of Johnson & Johnson's Bill Weldon--has drawn the ire of workers' unions, who called for a vote against the paychecks at company annual meetings this week.

Pfizer News:
Union urges votes against CEO pay at Pfizer, J&J
Report: Kindler resigns after not appointing Read
Jeffrey Kindler - 2009 CEO Pay

Jeffrey Kindler - 2010 CEO Pay
Read more on

Suggested Articles

While Lilly's 2018 launch Emgality is approved to prevent migraines, Reyvow is intended to treat them as they occur.

ICER's new draft review of RA drugs takes a different approach, reflecting how physicians treat the disease and the time horizon that's considered.

Johnson & Johnson is facing multibillion-dollar liabilities in thousands of talc and opioid cases. But that's not such a bad thing, one analyst said.